Proceedings from the GLP1 Meeting on the occasion of the 80th birthday of Prof. Dr. med. Dr. hc (em.) Werner CreutzfeldtSCHMIDT, W. E; NAUCK, M. A.Regulatory peptides. 2005, Vol 128, Num 2, issn 0167-0115, 83 p.Conference Proceedings

The [pre-] history of the incretin conceptCREUTZFELDT, Werner.Regulatory peptides. 2005, Vol 128, Num 2, pp 87-91, issn 0167-0115, 5 p.Conference Paper

The discovery of glucagon-like peptide 1LUND, P. Kay.Regulatory peptides. 2005, Vol 128, Num 2, pp 93-96, issn 0167-0115, 4 p.Conference Paper

What do we know about the secretion and degradation of incretin hormones?DEACON, Carolyn F.Regulatory peptides. 2005, Vol 128, Num 2, pp 117-124, issn 0167-0115, 8 p.Conference Paper

Glycaemic effects of incretins in Type 1 diabetes mellitus A concise review, with emphasis on studies in humansDUPRE, John.Regulatory peptides. 2005, Vol 128, Num 2, pp 149-157, issn 0167-0115, 9 p.Conference Paper

Glucagon-related peptide 1 (GLP-1) : Hormone and neurotransmitterLARSEN, Philip J; HOLST, Jens Juul.Regulatory peptides. 2005, Vol 128, Num 2, pp 97-107, issn 0167-0115, 11 p.Conference Paper

GIP and GLP-1 as incretin hormones : Lessons from single and double incretin receptor knockout miceHANSOTIA, Tanya; DRUCKER, Daniel J.Regulatory peptides. 2005, Vol 128, Num 2, pp 125-134, issn 0167-0115, 10 p.Conference Paper

Glucagon-like peptide 1 and its derivatives in the treatment of diabetesNAUCK, Michael A; MEIER, Juris J.Regulatory peptides. 2005, Vol 128, Num 2, pp 135-148, issn 0167-0115, 14 p.Conference Paper

The physiological role of GLP-1 in human : Incretin, ileal brake or more?SCHIRRA, Jorg; GÖKE, Burkhard.Regulatory peptides. 2005, Vol 128, Num 2, pp 109-115, issn 0167-0115, 7 p.Conference Paper

Dipeptidyl peptidase IV inhibitors : How do they work as new antidiabetic agents?MCINTOSH, Christopher H. S; DEMUTH, Hans-Ulrich; POSPISILIK, J. Andrew et al.Regulatory peptides. 2005, Vol 128, Num 2, pp 159-165, issn 0167-0115, 7 p.Conference Paper